Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating a regimen of liposomal doxorubicin, cyclophosphamide, and trastuzumab in stage IV HER2-positive breast cancer, including male breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxil (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: University of Washington | Conditions: HER2-positive Breast Cancer, Male Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-26